The biological activity of Humanin analogs correlates with structure stabilities in solution.
Arakawa. Tsutomu T; Niikura. Takako T; Kita. Yoshiko Y
Key Findings
- S14G‑Humanin is ~1000‑times more neuroprotective than the original peptide
- Stability of the peptide at 37 °C matches its activity: S14G‑HN is most stable, S7A‑HN is least
- Temperature and buffer conditions affect peptide structure, with higher temperatures causing rapid loss of structure in less active forms
Practical Outcomes
- For DIY biohackers, choosing the S14G‑Humanin analog may give stronger benefits and better shelf‑life at body temperature. Store peptides cold (around 10 °C) to preserve structure, especially for less stable variants. No dosage guidance is provided, so start with low amounts and monitor effects.
Summary
The study found that a tiny change in the Humanin peptide (switching serine to glycine at position 14) makes it far more stable at body temperature and dramatically boosts its brain‑protective effect, while another change (serine to alanine at position 7) does the opposite.
Abstract
A single mutation has resulted in large differences in neuroprotective activity of a 24 amino acid Humanin (HN). A mutation of Ser7Ala (S7A-HN) resulted in loss of activity, while a mutation of Ser14Gly (S14G-HN) resulted in about 1000-fold increase. The mechanism of the effects conferred by these mutations have been totally unclear, although our recent structure analysis suggested a possibility of the effect of mutation on the structure stability. Here, we have studied the effects of buffer and temperature on the structure of these three HN peptides. These peptides showed a similar disordered structure at 10°C in 10mM phosphate, pH 6.0. They were also similar in phosphate-buffered saline (PBS) as long as the temperature was kept low at 10°C. However, a large difference was observed in both phosphate buffer and PBS between the peptides, when the temperature was raised to a physiological temperature of 37°C. While S14G-HN showed small changes in both solutions at 37°C, the less active HN and inactive S7A-HN showed much larger changes under the identical conditions. In addition, it appeared that structure change at 37°C was faster for S7A-HN than HN. These results show that the structure stability at 37°C increases in the order of S7A-HN, HN and S14G-HN, in correlation with their neuroprotective activities.
Study Information
pubmed
2011
2011-04-12T00:00:00.000Z
10.1016/j.ijbiomac.2011.04.003
9
26